Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

Autor: Liu, H., Murphy, W. J., Sitcheran, R., Blazar, B. R., Barao, I., Serody, J. S., Welniak, L. A., O'Shaughnessy, M. J., Riordan, W., Panoskaltsis-Mortari, A., Wysocki, C., Sun, K., Sayers, T. J.

Graft-versus-host disease (GVHD) represents a major hurdle impeding the efficacy of allogeneic bone marrow transplantation (BMT). Bortezomib is a proteasome inhibitor that was recently approved for treatment of myeloma. We found that bortezomib poten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ba0f2c89ae8f63f4973715e9708f709

Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease

Autor: O'Shaughnessy, M. J., Vogtenhuber, C., Sun, K., Sitcheran, R., Baldwin, A. S., Murphy, W. J., Dang, L., Jaffee, B., Palmer, E., Serody, J. S., Blazar, B. R.

Publikováno v: American Journal of Transplantation; March 2009, Vol. 9 Issue: 3 p452-462, 11p

Diabetic ketoacidosis in pregnancy with a recent normal screening test.

Autor: O'Shaughnessy MJ; University Medical Center, University of California, San Francisco Fresno-Central San Joaquin Valley Medical Education Program, Fresno 93702, USA., Beingesser KR, Khieu WU

Publikováno v: The Western journal of medicine [West J Med] 1999 Feb; Vol. 170 (2), pp. 115-8.

Differentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans.

Autor: Kullen MJ; Department of Food Science and Nutrition, University of Minnesota, St. Paul 55108, USA., Amann MM, O'Shaughnessy MJ, O'Sullivan DJ, Busta FF, Brady LJ

Publikováno v: The Journal of nutrition [J Nutr] 1997 Jan; Vol. 127 (1), pp. 89-94.